Predictive Value of the KELIM Index for Progression-Free Survival in Ovarian Cancer Under Current Treatment Modalities
International Journal of Women's Health · 2025-07 · Volume 17 · 2291-2297
DOI: 10.2147/ijwh.s533323 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Women's Health, 2025-07. Verfasst von Jiajin Lv und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, The First Hospital of Jiaxing, Jiaxing, Zhejiang, People's Republic of China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
The KELIM index, a dynamic biomarker derived from CA125 kinetics, has shown prognostic value in ovarian cancer. However, its predictive role under contemporary treatment paradigms incorporating bevacizumab and PARP inhibitors remains underexplored.
Objective
To evaluate the predictive value of the KELIM index for progression-free survival (PFS) in ovarian cancer patients treated with current therapeutic modalities.
Methods
A total of 52 patients with ovarian cancer who underwent surgical treatment in the Affiliated Hospital of Jiaxing University from January 1, 2020 to September 30, 2023 were retrospectively analyzed. Clinicopathological data, treatment details (including bevacizumab/PARPi use), and serial CA125 values were collected. The KELIM index was calculated using the online biomarker kinetics tool (https://www.biomarker-kinetics.org/CA125). Cox regression and Kaplan-Meier analyses assessed prognostic factors.
Results
The mean age of the 52 patients was 55.17±13.57 years, and the mean body mass index (BMI) was 22.95±3.62kg/m2. There were 35 cases (67.3%) in the KELIM index ≥1 group and 17 cases (32.7%) in the KELIM index < 1 group. Multivariate analysis identified KELIM index (HR=0.25, 95% CI 0.077-0.818, P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology, The First Hospital of Jiaxing, Jiaxing, Zhejiang, People's Republic of China.
Zitieren
APA
Lv, J., Xu, Y., Zeng, C., Huang, F., & Tao, S. (2025). Predictive Value of the KELIM Index for Progression-Free Survival in Ovarian Cancer Under Current Treatment Modalities. International Journal of Women's Health, Volume 17, 2291-2297. https://doi.org/10.2147/ijwh.s533323
Vancouver
Lv J, Xu Y, Zeng C, Huang F, Tao S. Predictive Value of the KELIM Index for Progression-Free Survival in Ovarian Cancer Under Current Treatment Modalities. International Journal of Women's Health. 2025;Volume 17:2291-2297. doi:10.2147/ijwh.s533323
BibTeX
@article{Lv2025,
author = {Lv, Jiajin and Xu, Yunyi and Zeng, Chunyan and Huang, Fengyan and Tao, Suping},
title = {Predictive Value of the KELIM Index for Progression-Free Survival in Ovarian Cancer Under Current Treatment Modalities},
journal = {International Journal of Women's Health},
year = {2025},
volume = {Volume 17},
pages = {2291--2297},
doi = {10.2147/ijwh.s533323}
}
EUVIMED